血浆致动脉粥样硬化指数在冠心病中的应用进展  

Application of atherogenic index of plasma in coronary heart disease

作　　者：李沅萍 智慧敏 高奋[1] LI Yuan-ping;ZHI Hui-min;GAO Fen(Department of Cardiology,The Second Hospital of Shanxi Medical University,Taiyuan 030001,China)

机构地区：[1]山西医科大学第二医院心内科,山西省太原市030001

出　　处：《中国心血管病研究》2024年第12期1148-1152,共5页Chinese Journal of Cardiovascular Research

摘　　要：血浆致动脉粥样硬化指数是一项新型血脂综合指标,作为小而致密的低密度脂蛋白胆固醇的替换物,它易于获取,计算方法简便,能够全面反映致动脉粥样硬化和抗动脉粥样硬化脂蛋白之间的平衡,对冠心病的发生、发展以及预后的预测有重要的临床意义。本文归纳了血浆致动脉粥样硬化指数对冠心病患者早期诊断、风险评估以及介入治疗的临床应用价值,为后续冠心病相关防治提供思考和理论依据。Atherogenic index of plasma is a new comprehensive lipid index.As a replacement for small,dense low density lipoprotein cholestero,it is easy to obtain and simple to calculate.It can fully reflect the balance between atherogenic and anti-atherogenic lipoprotein,and has important clinical significance for the occurrence,development and prognosis of coronary heart disease.This paper summarizes the clinical application value of plasma arteriosclerosis index in the early diagnosis,risk assessment and interventional treatment of patients with coronary heart disease,and provides thinking and theoretical basis for the subsequent prevention and treatment of coronary heart disease.

关 键 词：血浆致动脉粥样硬化指数 心血管疾病 冠心病 

分 类 号：R541.4[医药卫生—心血管疾病]